ArticleCancer biology & therapy2018

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy.

Qiuli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.